Commentary on Prevention a Possible Drug–Drug Interaction: Is Concurrent Administration of Orlistat and Pioglitazone Increase the Risk of Durg-Induced Hepatotoxicity?

BACKGROUND: Drug–drug interactions (DDIs) are an emerging threat to public health and are difficult to detect. To prevent DDIs and their burden, the possible DDIs should be kept in mind. We know that the obesity predisposes to the development of insulin resistance and type 2 diabetes. Therefore, com...

Descripción completa

Detalles Bibliográficos
Autores principales: Emzhik, Marjan, Rahimi-Moghaddam, Parvaneh, Ebrahimi, Soltan Ahmad, Keyhanfar, Fariborz, Moazzam, Ashraf Sadat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362284/
https://www.ncbi.nlm.nih.gov/pubmed/25789148
http://dx.doi.org/10.4103/2008-7802.151825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362284/
https://www.ncbi.nlm.nih.gov/pubmed/25789148
http://dx.doi.org/10.4103/2008-7802.151825

Ejemplares similares